{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:49:10Z","timestamp":1771303750145,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,11,12]],"date-time":"2008-11-12T00:00:00Z","timestamp":1226448000000},"content-version":"vor","delay-in-days":9904,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Develop Med Child Neuro"],"published-print":{"date-parts":[[1981,10]]},"abstract":"<jats:sec><jats:title>SUMMARY<\/jats:title><jats:p>A seven\u2010year\u2010old girl with slowly progressive motor neurological impairment and high levels of lactate and pyruvate in blood and cerebrospinal fluid was found to have severe hepatic pyruvate carboxylase deficiency. However, in contrast to other patients with this deficiency, no mental retardation was apparent. Treatment with aspartic acid and thiamine over \u00e0 period of seven years resulted in biochemical improvement and \u00e0 stable neurological condition. The level of cognitive functioning remained the same.<\/jats:p><jats:p>When treatment with aspartic acid was temporarily discontinued, lactate and pyruvate concentrations increased so markedly that the drug was resumed. This indicates that aspartic acid was the effective drug, and that the effect of thiamine was secondary.<\/jats:p><\/jats:sec><jats:sec><jats:title>R\u00c9SUM\u00c9<\/jats:title><jats:p>Trailement par l'acide aspartique et la thiamine chez un madade presentant une insuffisance hepatique de la pyruvate carboxylase<\/jats:p><jats:p>Une insuffisance h\u00e9patique grave de la pyruvate carboxylase \u00e0\u00e9t\u00e9 observee chez une fillette de sept ans presentant une alt\u00e9ration neurologique motrice lentement progressive avec des taux \u00e9lev\u00e9s de lactate et de pyruvate dans le sang et le LCR. Cependant, aucun retard mental n'etait apparent en contraste avec ce qui est generalement observe avec cette insuffisance. Le traitement par acide aspartique et thiamine durant une p\u00e9riode de sept ans s'est traduit par une am\u00e9lioration biochimique et une condition neurologique stable. Le niveau des fonctions est rest\u00e9 le m\u00eame.<\/jats:p><jats:p>Lors de l'interruption temporaire du traitement par l'acide aspartique et la thiamine, les concentrations de lactate et de pyruvate augment\u00e8rent tellement que le traitement fut immediatement repris. Ceci indique que I'acide aspartique est le medicament efficace et que l'effet de la thiamine est seulement secondaire.<\/jats:p><\/jats:sec><jats:sec><jats:title>ZASUMMENFASSUNG<\/jats:title><jats:p>Ein Patient mit Pyruvatcarboxylasemangel der Leber: Behandlung mit Asparagins\u00e4ure und Thiamin<\/jats:p><jats:p>Bei einem sieben Jahre alten M\u00e4dchen mit langsam fortschreitender neuromuskul\u00e4rer Erkrankung und hohen Laktat\u2010 und Pyruvatspiegeln im Blut und im Liquor wurde ein schwerer hepatischer Pyruvatcarboxylasemangel diagnostiziert. Im Gegensatz zu anderen Patienten mit dieser Mangelerkrankung fand sich jedoch keine geistige Retardierung. Die Behandlung mit Asparagins\u00e4ure und Thiamin iiber einen Zeitraum von sieben Jahren bewirkte eine biochemische Besserung und einen gleichbleibenden neurologischen Befund. Der cognitive Leistungsstand blieb konstant.<\/jats:p><jats:p>Als die Asparagins\u00e4uretherapie vor\u00fcbergehend ausgesetzt wurde, stiegen die Laktat\u2010 und Pyruvatspiegel so stark an, da\u00df das Medikament wiederangesetzt wurde. Dies deutet darauf hin, daB die Asparaginsaure das wirksame Medikament ist und da\u00df die Wirkung von Thiamin sekund\u00e4r ist.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESUMEN<\/jats:title><jats:p>Un paciente con deflciencia de piruvato carboxilasa del hlgado: tratamiento con \u00e1cido asp\u00e1rtico y tiamina<\/jats:p><jats:p>Una ni\u00f1a de siete a\u00f1os de edad con alterati\u00f3n neurol\u00f3gica motora lentamente progresiva y altos niveles de lactato y piruvato en sangre y liquido cefaloraqu\u00eddeo, se vio que ten\u00eda una deficiencia grave de piruvato carboxilasa hep\u00e1tica. Sin embargo, en contraste con otros pacientes con esta deficiencia, no habia ningun retraso mental aparente. El tratamiento con acido aspartico y tiamina durante un periodo de siete a\u00f1os habia doda lugar \u00e0 una mejoria bioqu\u00edmica y una situati\u00f3n neurol\u00f3gica estable. El nivel de la funciones cognitivas permanec\u00eda igual.<\/jats:p><jats:p>Cuando se interrumpti\u00f3 temporalmente el tratamiento con \u00e1cido asp\u00e1rtico, aumentaron las concentraciones del lactato y piruvato de forma tan marcada que el tratamiento se reinstauro. Esto indica que el \u00e1cido asp\u00e1rtico era el f\u00e1rmaco efectivo, y que el efecto de la tiamina era secundario.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1469-8749.1981.tb02026.x","type":"journal-article","created":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T06:45:30Z","timestamp":1279176330000},"page":"521-530","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A Patient with Pyruvate Carboxylase Deficiency in the Liver: Treatment with Aspartic Acid and Thiamine"],"prefix":"10.1111","volume":"23","author":[{"given":"M. G.","family":"Baal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. J. M.","family":"Gabre\u00ebls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. O.","family":"Renter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. A.","family":"Hommes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th. H. J.","family":"Gijsbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. J. B.","family":"Lamers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C. N.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,11,12]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-197902000-00005"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-197901000-00009"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.29.3.280"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1542\/peds.50.5.702","article-title":"Thiamine\u2010responsive lactic acidosis in a patient with deficient low\u2010KM pyruvate carboxylase activity in liver","volume":"50","author":"Brunette G.","year":"1972","journal-title":"Pediatrics"},{"key":"e_1_2_1_6_1","first-page":"581","article-title":"Poliodystrophie cerebrale infantile (maladie \u010fAlpers) chez un nourrisson avec hyper\u2010lactacidemie et anomalie de la pyruvate carboxylase hepatique","volume":"32","author":"David M.","year":"1975","journal-title":"Archives Francoises de P\u00e9diatrie"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(73)80144-1"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-45-6-1281"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(74)90031-6"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1975.tb03916.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(72)80371-8"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.43.230.423"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00466274"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/S0021-9258(19)67962-7","article-title":"Mammalian liver phosphoenolpyruvate carboxylase activities","volume":"238","author":"Nordlie R. C.","year":"1963","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_1_15_1","first-page":"717","article-title":"Neonatal congenital lactic acidosis with pyruvate carboxylase deficiency in two siblings","volume":"65","author":"Saudubray J. M.","year":"1976","journal-title":"Acta Paediatrica Scandinavica"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00445770"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.97.99"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(72)80428-1"},{"key":"e_1_2_1_19_1","first-page":"337","article-title":"Poliodystrophie cerebrale infantile \u010fAlpers. Un cas avec anomalie de la pyruvate\u2010carboxylase hepatique","volume":"22","author":"Tommassi M.","year":"1976","journal-title":"Anales \u010fAnatomie Pathologique"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/S0021-9258(18)67873-1","article-title":"Pyruvate carboxylase. I. Nature and reaction","volume":"238","author":"Utter M. F.","year":"1963","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1977.tb08376.x"},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/clinchem\/24.2.200","article-title":"Determination of pyruvate oxidation rate and citric acid cycle activity in intact human leucocytes and fibroblasts","volume":"24","author":"Willems H. L.","year":"1978","journal-title":"Clinical Chemistry"},{"key":"e_1_2_1_23_1","first-page":"561","article-title":"The glycemic response to alanine: index to glucagons secretion in man","volume":"20","author":"Wise J. K.","year":"1972","journal-title":"Clinical Research."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.99.121"}],"container-title":["Developmental Medicine &amp; Child Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1469-8749.1981.tb02026.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1469-8749.1981.tb02026.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T18:54:08Z","timestamp":1699124048000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1469-8749.1981.tb02026.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,10]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1981,10]]}},"alternative-id":["10.1111\/j.1469-8749.1981.tb02026.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-8749.1981.tb02026.x","archive":["Portico"],"relation":{},"ISSN":["0012-1622","1469-8749"],"issn-type":[{"value":"0012-1622","type":"print"},{"value":"1469-8749","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,10]]},"assertion":[{"value":"2008-11-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}